Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

616.16 +16.69 (+2.78%)

Delayed Quote Updated: 1:41 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

1 Mid-Cap Stock for Long-Term Investors and 2 We Avoid

April 13, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

MEDP INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit

April 11, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 10, 2026

From Schall Law

Via GlobeNewswire

Medpace Holdings Inc (NASDAQ:MEDP) Passes Key CAN SLIM Filters Amid Market Caution ↗

March 30, 2026

Via Chartmill

Medpace Holdings Inc (NASDAQ:MEDP) Passes Key CAN SLIM Growth Filter Amid Technical Caution ↗

March 09, 2026

Via Chartmill

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Medpace Holdings, Inc. (MEDP) Shareholders To Inquire About Securities Fraud Class Action

April 10, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Law Offices of Howard G. Smith Encourages Medpace Holdings, Inc. (MEDP) Shareholders To Inquire About Securities Fraud Class Action

April 09, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Law Offices of Frank R. Cruz Encourages Medpace Holdings, Inc. (MEDP) Shareholders To Inquire About Securities Fraud Class Action

April 09, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MEDP

April 09, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Securities Fraud Investigation Into Medpace Holdings, Inc. (MEDP) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

April 08, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money �� Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

April 08, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Medpace Holdings, Inc. (MEDP) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

April 07, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the Medpace Holdings Inc. Class Action

April 07, 2026

From Robbins LLP

Via Business Wire

Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their Rights

April 07, 2026

From Rosen Law Firm

Via Business Wire

MEDPACE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

April 07, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026

April 07, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MEDP

April 07, 2026

From DJS Law Group

Via Business Wire

MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 07, 2026

From Schall Law

Via GlobeNewswire

3 Market-Beating Stocks with Exciting Potential

April 07, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...

Via StockStory

Topics Credit Cards

MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 06, 2026

From The Schall Law Firm

Via Business Wire

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

April 03, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

3 Big Reasons MEDP Should Be On Your Watchlist

April 01, 2026

Over the past six months, Medpace’s shares (currently trading at $483.21) have posted a disappointing 11.2% loss while the S&P 500 was down 5.5%. This might ...

Via StockStory

Topics Stocks

Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026

March 24, 2026

From Medpace Holdings, Inc.

Via Business Wire

Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 22, 2026

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...

Via StockStory

2 Healthcare Stocks with Exciting Potential and 1 We Avoid

March 09, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

Via StockStory

3 Profitable Stocks for Long-Term Investors

March 05, 2026

Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance pro...

Via StockStory

Medpace (NASDAQ:MEDP): Strongest Q4 Results from the Drug Development Inputs & Services Group

March 01, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how drug development inputs & services stocks fared in Q4,...

Via StockStory

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Government World Trade

Investment Manager Bets Big on Varonis Stock, According to Recent SEC Filing ↗

February 23, 2026

Varonis Systems provides data security and analytics software to global enterprises, helping organizations manage access and compliance.

Via The Motley Fool

Topics Regulatory Compliance

American Capital Management Doubles Down on Novanta Stock, According to Latest SEC Filing ↗

February 19, 2026

Novanta delivers advanced photonics and precision motion components for medical and industrial OEMs worldwide.

Via The Motley Fool

Topics Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.